title: Dalteparin sodium injection treatment in patients with immunologic recurrent pregnancy loss.
abstract: Dalteparin sodium injection in patients with an immunologic component to RPL resulted in an increase in compliance without any adverse early pregnancy outcomes.
authors.affiliation: Delaware Institute for Reproductive Medicine, Milford, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Trott
authors.forename: A M
authors.initials: AM
authors.lastname: Trott
mesh_terms: D000026:Abortion, Habitual / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage*; D017985:Dalteparin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D012189:Retrospective Studies
chemical_list: D000925:Anticoagulants; D017985:Dalteparin